Zhouao Zhang

Efgartigimod for generalized myasthenia gravis: A multicenter real‐world cohort study in China

Sushan Luo, Qilong Jiang, Wenshuang Zeng et al. · Annals of Clinical and Translational Neurology · 2024 · 43 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +11

The systemic inflammation markers as possible indices for predicting respiratory failure and outcome in patients with myasthenia gravis

Xiaoyu Huang, Mingming Xu, Yingying Wang et al. · Annals of Clinical and Translational Neurology · 2022 · 31 citations · Full text

Veterinary Medicine, Immunology, Internal Medicine +16

Patterns and predictors of therapeutic response to efgartigimod in acetylcholine receptor-antibody generalized myasthenia gravis subtypes

Lei Jin, Zhang‐Yu Zou, Qinzhou Wang et al. · Therapeutic Advances in Neurological Disorders · 2025 · 21 citations · Full text

Life Sciences, Internal Medicine, Neurology +15

Associations of Inflammatory Markers With Neurological Dysfunction and Prognosis in Patients With Progressive Stroke

Zhouao Zhang, Xiaoyu Hang, Wei Wang · European Journal of Neurology · 2025 · 17 citations · Full text

Life Sciences, Clinical Sciences, Neurology +17

Perioperative Safety and Efficacy of Efgartigimod for Thymoma-Associated Myasthenia Gravis: A Prospective, Multicenter, Phase II Clinical Trial

Shuai Wang, Min Zhu, Jihong Dong et al. · Journal of Thoracic Oncology · 2025 · 15 citations

Medicine, Perioperative Medicine, Surgery +9